No Photo Available

Last Update

2011-04-04T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Francesco Melandri?

Mr. Francesco D. Melandri

President and Chief Executive Officer

Boston Biochem , Inc.

HQ Phone: (617) 241-7072

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Boston Biochem , Inc.

840 Memorial Drive

Cambridge, Massachusetts 02139

United States

Company Description

Boston Biochem, Inc. is the world's leading producer of Ubiquitin Proteasome Pathway products. Since our founding in 1997, it has been our mission to provide customers with innovative reagents for their research needs. All of our specialized reagents are ... more

Find other employees at this company (13)

Background Information

Web References (6 Total References)


News from Katan Assocaites

www.katanassociates.com [cached]

With these acquisitions we will be able to expand our reputation for offering high quality research reagents throughout the world." Boston Biochem founder and President, Francesco Melandri, added "The transaction with Techne Corporation is strategically ideal for Boston Biochem. The importance of ubiquitin in the regulation of disease continues to grow and with this comes large and continuing increased in demand for discovery tools worldwide. Techne's commitment to ubiquitin-related research coupled to support of Boston Biochem's development capabilities will significantly accelerate our ability to expand and meet these research needs, for both basic and drug discovery. I have every confidence that this strategy will allow the Boston Biochem brand to maintain its leadership and reputation worldwide in this critical area of study well into the future." Mr. Melandri will continue to lead the ongoing product development of ubiquitin-related products and will remain active in promoting and enhancing relationships with customers and the ubiquitin research communities. Our press releases may contain forward-looking statements within the meaning of the Private Litigation Reform Act.


Welcome to Katan Associates

www.katanassociates.com [cached]

Boston Biochem founder and President, Francesco Melandri, added "The transaction with Techne Corporation is strategically ideal for Boston Biochem. The importance of ubiquitin in the regulation of disease continues to grow and with this comes large and continuing increased in demand for discovery tools worldwide. Techne's commitment to ubiquitin-related research coupled to support of Boston Biochem's development capabilities will significantly accelerate our ability to expand and meet these research needs, for both basic and drug discovery. I have every confidence that this strategy will allow the Boston Biochem brand to maintain its leadership and reputation worldwide in this critical area of study well into the future."

Mr. Melandri will continue to lead the ongoing product development of ubiquitin-related products and will remain active in promoting and enhancing relationships with customers and the ubiquitin research communities.


"We are extremely pleased and thankful ...

www.bostonbiochem.com [cached]

"We are extremely pleased and thankful to receive this grant from the Massachusetts Life Sciences Center," said Francesco Melandri, President & CEO of Boston Biochem.


Pharma services firm embarks on expansion - 2005-07-18

boston.bizjournals.com [cached]

Francesco Melandri

...
CAMBRIDGE -- After years working as a researcher for small biotechnology and pharmaceutical companies, Francesco Melandri launched his own venture to counter a sobering reality: Drug development can be risky and isn't often successful.
...
"I wanted to come up with a way where there was less inherent risk and still do what I like to do," Melandri recalled."We've achieved that."
Melandri is founder, president and CEO of Boston Biochem Inc. in Cambridge, a 15-employee company that contracts with larger pharmaceutical and biotechnology companies to make custom reagents and proteins that help facilitate drug discovery.
The 8-year-old private company has embarked on expansion.
...
Melandri said his company has been profitable and rang up between $1 million and $3 million in revenue in 2004, a range the company first cracked in 2002.


New England Technology Directory | Mass High Tech

directory.masshightech.com [cached]

Francesco Melandri President/CEO

Similar Profiles

Other People with this Name

Other people with the name Melandri

Massimo Melandri
Eni

Lucio Melandri
UNICEF

Francesca Melandri
Italy Srl

Fabio Melandri
Sacmi Service

Lisa Melandri
Contemporary Art Museum St. Louis

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory